Aug 2026· IEEE journal of biomedical and health informatics· Vol PP· 0 citations
Medicine
TL;DR
Results reveal that MAGNETIC consistently out performs baselines on both the area under the receiver operating characteristic curve (AUROC) and the area under the precision-recall curve (AUPRC), indicating improved identification and ranking of true interactions under class imbalance.
Abstract
Drug target interaction (DTI) prediction is a critical task in drug discovery, as it has the potential to accelerate the identification of promising drug-target interactions, thus leading to more efficient and focused wet lab validations. Our central premise is that modeling DTI as a multilayer attributed heterogeneous graph and learning layer-specific representations with diffusion-based graph neural networks (GNNs) improves predictive performance over conventional single-view graph learning and matrix factorization approaches. To test this premise, we pro pose Multilayer Attention and Graph Neural nETwork dIffusion for effeCtive Drug-Target Interaction prediction (MAG NETIC). MAGNETIC is a graph auto-encoder framework that represents drugs and targets in a multiplex network. It further incorporates meta-path-derived drug-drug and target-target similarity relations. MAGNETIC trains a separate Adaptive Graph Diffusion Network (AGDN) per layer to preserve layer-specific topology and attributes, then combines embeddings through learnable layer weights to produce a unified representation for DTI inference. The model is optimized with a reconstruction objective tailored to the sparse and imbalanced DTI setting. We evaluate MAGNETIC against strong graph neural network and matrix factorization baselines across multiple experimental scenarios. Results reveal that MAGNETIC consistently out performs baselines on both the area under the receiver operating characteristic curve (AUROC) and the area under the precision-recall curve (AUPRC). The largest gains are observed in AUPRC, indicating improved identification and ranking of true interactions under class imbalance. Finally, a real-world validation study on previously undiscovered DTIs provides additional evidence of the model's practical utility for novel interaction discovery.
Predicting drug–target interactions is critical for drug discovery, yet many deep learning methods overlook atom–residue–level relationships, so PHGDTI is proposed, a multimodal framework that integrates sequence and structural cues for binding prediction.
Hua Qian, Deng Pan, Liangpeng Nie et al.· Journal of Computational Bio...· 0 citations
IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.
Guolongwei Dai, Tao Luo, Dandan Li et al.· ACS Synthetic Biology· 0 citations
Results indicate that integrating heterogeneous structural cues through coarse- and fine-grained feature interaction provides an effective and scalable solution for DDI prediction.
A novel multiview feature fusion-based graph representation model (MFF-GRM) for predicting DDI that integrates drug molecular graphs, SMILES sequences, DDI information networks, and drug biological features to learn drug features more comprehensively.
Mengyuan Jin, Dan Liu, E. Benfenati et al.· Applied intelligence (Boston...· 0 citations
A multi-modal deep learning framework to predict drug-target affinity by integrating sequence semantics with graph structural information and design a new symmetric dual cross-attention fusion mechanism for drugs and targets.
Wei Lan, Tian Huang, Guohang He et al.· IEEE journal of biomedical a...· 0 citations
Drug-target interaction (DTI) prediction is an efficient pre-screening method that uses algorithmic models to assess the binding potential of drug molecules to protein targets. Current research is accelerating towards the integration of heterogeneous graph neural networks, protein language models, and generative artificial intelligence. This review systematically summarizes the latest developments in these technologies, pointing out the problems currently being addressed in research such as data sparsity and cold start, as well as the manifestations of general machine learning challenges such as recommendation systems and noise learning in the biomedical field; Interpret representative models such as Dual Heterogeneous Graph Transformer for Drug-Target Interaction (DHGT-DTI) and Graph Positional encoding and Sequence features for Drug-Target Interaction (GPS-DTI). The combination of dual perspective learning, equivariant graph convolution, and attention mechanism enhances the understanding and reasoning ability of these models in complex biological networks. The generative artificial intelligence diffusion model has opened up a path for developing new drugs through structured and data enhanced approaches. Research has shown that important issues related to computational performance, interpretability, and data compatibility still need to be addressed in existing models. Building a high-performance, multifunctional pre trained model for large-scale biomolecules should be a key direction for development.
Qi-Zhong Yang· ITM Web of Conferences· 0 citations